Live Breaking News & Updates on Docia

Stay informed with the latest breaking news from Docia on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Docia and stay connected to the pulse of your community

Listing of ADOCIA Shares Suspended

Regulatory News: Adocia (Euronext Paris: FR0011184241 ADOC), a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment

Olivier-soula , Pierre-louis-germain , Euronext , Regulatory-news , Euronext-paris , French-autorit , Investors-relations , Puech-pays , Listing , Docia , Hares , Uspended

Number of Shares and Voting Rights of ADOCIA as of January 31st, 2023

Regulatory News: ADOCIA (Paris:ADOC): Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés

Lacassagne , Midi-pyrées , France , Paris , France-general- , Puech , French , Dennis-riedl , Pierre-louis-germain , Company-on , Euronext , Regulatory-news

Number of Shares and Voting Rights of ADOCIA as of October 31st, 2022

Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF")

Lacassagne , Midi-pyrées , France , Paris , France-general- , Puech , French , Pierre-louis-germain , Company-on , Euronext , Regulatory-news , French-code-de-commerce

Number of Shares and Voting Rights of ADOCIA as of September 30th, 2022

Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF")

Lacassagne , Midi-pyrées , France , Puech , French , Pierre-louis-germain , Company-on , Euronext , Regulatory-news , French-code-de-commerce , Des-march , Euronext-paris

Adocia: ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes

AdoShell Islets regulated glycemic control in immunocompetent diabetic animals in a 132-day trial without the use of insulin or immunosuppression. These results will be presented at the upcoming

Boston , Massachusetts , United-states , France , Puech , Midi-pyrées , French , Karim-bouzakri , Olivier-soula , Pierre-louis-germain , Health-insurance , European-center

Adocia: ADOCIA Reports Cash and Revenue for the Second Quarter and Provides Corporate Update

Reinforced cash position of €23.9m at the end of June 2022 due to a $5m milestone payment from our partner Tonghua Dongbao (THDB) received in May 2022 Increase of first half revenues with

China , France , Puech , Midi-pyrées , Chinese , Olivier-martinez , Biochaperone-lispro , Pierre-louis-germain , Eli-lilly , Laurent-arthaud , Tonghua-dongbao , European-diabetes-congress

Adocia: ADOCIA Reports Financial Results of First Quarter 2022 and Provides Corporate Update

19 million euros received for the sale of its building locate in Lyon and the concomitant signature of a 12-year renewable lease 25.3 million cash position as of March 31, 2022 Significant

China , Chinese , Biochaperone-lispro , Ahmad-haidar , Pierre-louis-germain , Tonghua-dongbao , China-drug-agency , Chinese-drug-agency , Mcgill-university , Euronext , Ultra-rapid-insulin , Euronext-paris

Adocia: Number of Shares and Voting Rights of ADOCIA as of March 31st, 2022

Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French Code de Commerce and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF")

Lacassagne , Midi-pyrées , France , Paris , France-general- , Puech , French , Pierre-louis-germain , Company-on , French-national-institute-of-industrial-property , Euronext , Regulatory-news

Adocia: ADOCIA Announces Start of 3 Clinical Studies for BioChaperone Combo with Partner Tonghua Dongbao

These clinical studies conducted in Germany will contribute to the dossier for phase 3 studies in China BioChaperone Combo targets the premix insulin market, which accounts for 65% of insulin

Jilin , China , Germany , Shanghai , Paris , France-general- , France , Puech , Midi-pyrées , French , Chinese , Olivier-soula

Adocia: ADOCIA Strengthens Its Cash Position by 19 Million Euros Following a Real Estate Transaction

The Company announces the sale of its building in Lyon in a sale and leaseback transaction worth over 20 million euros This transaction results in a net cash inflow of 19 million euros and

Paris , France-general- , France , Puech , Midi-pyrées , French , Pierre-louis-germain , Asset-management-company , French-national-institute-of-industrial-property , Euronext , Euronext-paris , Chief-financial-officer